Skip to main content
AAN.com

Abstract

Objective

To determine which findings on routine clinical EEGs correlate with delirium severity across various presentations and to determine whether EEG findings independently predict important clinical outcomes.

Methods

We prospectively studied a cohort of nonintubated inpatients undergoing EEG for evaluation of altered mental status. Patients were assessed for delirium within 1 hour of EEG with the 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM) and 3D-CAM severity score. EEGs were interpreted clinically by neurophysiologists, and reports were reviewed to identify features such as theta or delta slowing and triphasic waves. Generalized linear models were used to quantify associations among EEG findings, delirium, and clinical outcomes, including length of stay, Glasgow Outcome Scale scores, and mortality.

Results

We evaluated 200 patients (median age 60 years, IQR 48.5–72 years); 121 (60.5%) met delirium criteria. The EEG finding most strongly associated with delirium presence was a composite of generalized theta or delta slowing (odds ratio 10.3, 95% confidence interval 5.3–20.1). The prevalence of slowing correlated not only with overall delirium severity (R2 = 0.907) but also with the severity of each feature assessed by CAM-based delirium algorithms. Slowing was common in delirium even with normal arousal. EEG slowing was associated with longer hospitalizations, worse functional outcomes, and increased mortality, even after adjustment for delirium presence or severity.

Conclusions

Generalized slowing on routine clinical EEG strongly correlates with delirium and may be a valuable biomarker for delirium severity. In addition, generalized EEG slowing should trigger elevated concern for the prognosis of patients with altered mental status.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, Washington, DC: American Psychiatric Association; 2013.
2.
D'Esposito M. Profile of a neurology residency. Arch Neurol 1995;52:1123–1126.
3.
Cruz-Velarde JA, Gil de Castro R, Vázquez Allén P, Ochoa Mulas M. Study of inpatient consultation for the neurological services [in Spanish]. Neurol Barc Spain 2000;15:199–202.
4.
Ances B. The more things change the more they stay the same: a case report of neurology residency experiences. J Neurol 2012;259:1321–1325.
5.
Rockwood K, Cosway S, Carver D, Jarrett P, Stadnyk K, Fisk J. The risk of dementia and death after delirium. Age Ageing 1999;28:551–556.
6.
Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Prognostic significance of delirium in frail older people. Dement Geriatr Cogn Disord 2005;19:158–163.
7.
Buurman BM, Hoogerduijn JG, de Haan RJ, et al. Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional decline. PLoS One 2011;6:e26951.
8.
Yanamadala M, Wieland D, Heflin MT. Educational interventions to improve recognition of delirium: a systematic review. J Am Geriatr Soc 2013;61:1983–1993.
9.
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med 1990;113:941–948.
10.
Marcantonio ER, Ngo LH, O'Connor M, et al. 3D-CAM: derivation and validation of a 3-minute diagnostic interview for CAM-defined delirium: a cross-sectional diagnostic test study. Ann Intern Med 2014;161:554–561.
11.
Numan T, van den Boogaard M, Kamper AM, et al. Recognition of delirium in postoperative elderly patients: a multicenter study. J Am Geriatr Soc 2017;65:1932–1938.
12.
Vasunilashorn SM, Fong TG, Albuquerque A, et al. Delirium severity post-surgery and its relationship with long-term cognitive decline in a cohort of patients without dementia. J Alzheimers Dis 2018;61:347–358.
13.
Cole M, McCusker J, Dendukuri N, Han L. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003;51:754–760.
14.
Ouimet S, Riker R, Bergeron N, et al. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007;33:1007–1013.
15.
Romano J, Engel GL. Delirium, I: electroencephalographic data. Arch Neurol Psychiatry 1944;51:356–377.
16.
van der Kooi AW, Zaal IJ, Klijn FA, et al. Delirium detection using EEG: what and how to measure. Chest 2015;147:94–101.
17.
Shafi MM, Santarnecchi E, Fong TG, et al. Advancing the neurophysiological understanding of delirium. J Am Geriatr Soc 2017;65:1114–1118.
18.
Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957;273:867–871.
19.
Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992;9:145–152.
20.
Thomas C, Hestermann U, Kopitz J, et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neurosci 2008;9:86.
21.
Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med 2010;363:2638–2650.
22.
Vasunilashorn SM, Guess J, Ngo L, et al. Derivation and validation of a severity scoring method for the 3-Minute Diagnostic Interview for Confusion Assessment Method–defined delirium. J Am Geriatr Soc 2016;64:1684–1689.
23.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81–84.
24.
Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166:1338–1344.
25.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
26.
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–484.
27.
Zafar SF, Postma EN, Biswal S, et al. Electronic health data predict outcomes after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2018;28:184–193.
28.
Meagher DJ, Moran M, Raju B, et al. Phenomenology of delirium: assessment of 100 adult cases using standardised measures. Br J Psychiatry J Ment Sci 2007;190:135–141.
29.
Kloke JD, McKean JW. Rfit: rank-based estimation for linear models. R J 2012;4:57–64.
30.
Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993;80:27–38.
31.
Heinze G, Ploner M. Fixing the nonconvergence bug in logistic regression with SPLUS and SAS. Comput Methods Programs Biomed 2003;71:181–187.
32.
R Core Team. R: A Language and Environment for Statistical Computing [online]. R Foundation for Statistical Computing. 2015. Accessed at: R-project.org/. Accessed May 8, 2018.
33.
Inouye SK, Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet 2014;383:911–922.
34.
Gloor P, Ball G, Schaul N. Brain lesions that produce delta waves in the EEG. Neurology 1977;27:326–333.
35.
Maldonado JR. Delirium pathophysiology: an updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry 2018;33:1428–1457.
36.
Hosokawa K, Gaspard N, Su F, Oddo M, Vincent JL, Taccone FS. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care 2014;18:674.
37.
Sutter R, Stevens RD, Kaplan PW. Clinical and imaging correlates of EEG patterns in hospitalized patients with encephalopathy. J Neurol 2013;260:1087–1098.
38.
Azabou E, Fischer C, Mauguiere F, et al. Prospective cohort study evaluating the prognostic value of simple EEG parameters in postanoxic coma. Clin EEG Neurosci 2016;47:75–82.
39.
Azabou E, Magalhaes E, Braconnier A, et al. Early standard electroencephalogram abnormalities predict mortality in septic intensive care unit patients. PLoS One 2015;10:e0139969.
40.
Sutter R, Kaplan PW, Cervenka MC, et al. Electroencephalography for diagnosis and prognosis of acute encephalitis. Clin Neurophysiol 2015;126:1524–1531.
41.
Poothrikovil RP, Gujjar AR, Al-Asmi A, Nandhagopal R, Jacob PC. Predictive value of short-term EEG recording in critically ill adult patients. Neurodiagnostic J 2015;55:157–168.
42.
Jacobson SA, Leuchter AF, Walter DO. Conventional and quantitative EEG in the diagnosis of delirium among the elderly. J Neurol Neurosurg Psychiatry 1993;56:153–158.
43.
Thomas C, Hestermann U, Walther S, et al. Prolonged activation EEG differentiates dementia with and without delirium in frail elderly patients. J Neurol Neurosurg Psychiatry 2008;79:119–125.
44.
Trzepacz PT, Mulsant BH, Dew MA, Pasternak R, Sweet RA, Zubenko GS. Is delirium different when it occurs in dementia? A study using the Delirium Rating Scale. J Neuropsychiatry Clin Neurosci 1998;10:199–204.
45.
Brown EG, Josephson SA, Anderson N, Reid M, Lee M, Douglas VC. Evaluation of a multicomponent pathway to address inpatient delirium on a neurosciences ward. BMC Health Serv Res 2018;18:106.
Letters to the Editor
7 September 2019
Reader response: Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes
Nitin K. Sethi, Associate Professor of Neurology | New York-Presbyterian Hospital, Weill Cornell Medical Center (New York, NY)

I read with interest Kimchi et al.1 article on clinical EEG slowing correlating with delirium severity. My own experience has been that, while in most patients with delirium, the EEG shows the absence of a well-defined posterior dominant rhythm, diffuse theta or delta or a mixed frequency background with, at times, superimposed broad sharp waves manifesting triphasic morphology, the degree of slowing by itself does not correlate with delirium severity or clinical outcomes. Rather, it is the presence or absence of reactivity, state changes, and sleep architecture which correlates with the degree of diffuse cerebral dysfunction.

Disclosure

The author reports no relevant disclosures. Contact [email protected] for full disclosures.

Reference

  1. Kimchi EY, Neelagiri A, Whitt W, et al. Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes. Neurology 2019 Epub  Aug 29.

Information & Authors

Information

Published In

Neurology®
Volume 93Number 13September 24, 2019
Pages: e1260-e1271
PubMed: 31467255

Publication History

Received: January 18, 2019
Accepted: April 30, 2019
Published online: August 29, 2019
Published in print: September 24, 2019

Permissions

Request permissions for this article.

Disclosure

E. Kimchi received funding from NIH–National Institute on Aging (1R03AG050878) and NIH–National Institute of Mental Health (1K08MH11613501). A. Neelagiri, W. Whitt, A. Sagi, S. Ryan, G. Gadbois, and D. Groothuysen report no disclosures relevant to the manuscript. M. Westover received funding from NIH–National Institute of Neurological Disorders and Stroke (1K23NS090900, 1R01NS102190, 1R01NS102574, 1R01NS107291) and the Department of Neurology, Massachusetts General Hospital, Boston. Go to Neurology.org/N for full disclosures.

Study Funding

E.Y.K. received funding from NIH–National Institute on Aging (1R03AG050878) and NIH–National Institute of Mental Health (1K08MH11613501). M.B.W. received funding from NIH–National Institute of Neurological Disorders and Stroke (1K23NS090900, 1R01NS102190, 1R01NS102574, 1R01NS107291) and the Department of Neurology, Massachusetts General Hospital, Boston.

Authors

Affiliations & Disclosures

Eyal Y. Kimchi, MD, PhD
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Anudeepthi Neelagiri, MBBS
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Wade Whitt, BS
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Avinash Rao Sagi, MD
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Sophia L. Ryan, MD
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Risk Management Foundation of the Harvard Medical Institutions (CRICO) HMS Fellowship in Patient Safety & Quality grant
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Greta Gadbois, BS
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Daniël Groothuysen, BS
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M. Brandon Westover, MD, PhD
From the Department of Neurology (E.Y.K., A.N., W.W., A.R.S., S.L.R., G.G., D.G., M.B.W.) and Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
Pocket Neurology, Lippincott Williams & Wilkins (2010).Pocket Neurology, 2nd Edition, Walters-Kluwer (2016).
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH (1K23NS090900, 1R01NS102190, 1R01NS102574, 1R01NS107291
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Kimchi [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Risk Factors for Post-Stroke Seizures in a Tertiary Care Center: A Case–Control Study, Neuropsychiatric Disease and Treatment, Volume 20, (1615-1628), (2024).https://doi.org/10.2147/NDT.S473483
    Crossref
  2. Electroencephalography as a tool for assessing delirium in hospitalized patients: A single-center tertiary hospital experience, Journal of Central Nervous System Disease, 16, (2024).https://doi.org/10.1177/11795735241274203
    Crossref
  3. The Role of Electroencephalography in Children with Acute Altered Mental Status of Unknown Etiology: A Prospective Study, Neuropediatrics, (2024).https://doi.org/10.1055/a-2380-6743
    Crossref
  4. DeltaScan for the Assessment of Acute Encephalopathy and Delirium in ICU and non-ICU Patients, a Prospective Cross-Sectional Multicenter Validation Study, The American Journal of Geriatric Psychiatry, 32, 9, (1093-1104), (2024).https://doi.org/10.1016/j.jagp.2023.12.005
    Crossref
  5. Investigating delirium in stroke with an EEG lens: Focal lesions with global impact?, Clinical Neurophysiology, 162, (219-221), (2024).https://doi.org/10.1016/j.clinph.2024.03.028
    Crossref
  6. Prevalence of clinical electroencephalography findings in stroke patients with delirium, Clinical Neurophysiology, 162, (229-234), (2024).https://doi.org/10.1016/j.clinph.2024.03.004
    Crossref
  7. Precise prediction of cerebrospinal fluid amyloid beta protein for early Alzheimer's disease detection using multimodal data, MedComm, 5, 5, (2024).https://doi.org/10.1002/mco2.532
    Crossref
  8. Delirium in a Child in Pediatric Intensive Care Unit, Advanced Biomedical Research, 12, 1, (2023).https://doi.org/10.4103/abr.abr_196_21
    Crossref
  9. Delirium in the intensive care unit: a narrative review, Journal of Gerontology and Geriatrics, 71, 1, (22-29), (2023).https://doi.org/10.36150/2499-6564-N600
    Crossref
  10. The Usefulness of Quantitative Electroencephalography in Diagnosis and Severity Evaluation of Delirium: A Retrospective Study, Psychiatry Investigation, 20, 2, (144-151), (2023).https://doi.org/10.30773/pi.2022.0294
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

View Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share